INS and diabetes mellitus: Further research is evaluating whether helminth-derived molecules could be developed as novel therapeutic approaches to diabetes and metabolic syndrome.82 In addition, a prospective randomised-control trial of helminth eradiation by albendazole therapy in Indonesia83 is underway evaluating the impact of helminth infections on insulin resistance.